Aquestive Therapeutics, Inc. (AQST), a pharmaceutical company focused on advancing innovative medicines, has several important catalysts on the horizon in 2025 that could shape its long-term trajectory.
The company's lead product candidates, Anaphylm (epinephrine) Sublingual Film and AQST-108 (epinephrine) Topical Gel, are making significant progress, with pivotal milestones expected to drive value for the company.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.